Volker Hanf
Furth, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Prospective validation of the prognostic and predictive impact of uPA/PAI-1 in early breast cancer.
Journal: Breast cancer research and treatment
Published: June 04, 2025
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 27, 2025
Correction: Prognostic and predictive impact of NOTCH1 in early breast cancer.
Journal: Breast cancer research and treatment
Published: November 20, 2024
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial.
Journal: International journal of cancer
Published: September 20, 2024
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 08, 2024
Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Journal: Geburtshilfe und Frauenheilkunde
Published: May 01, 2024
Prognostic and predictive impact of NOTCH1 in early breast cancer.
Journal: Breast cancer research and treatment
Published: February 26, 2024
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Journal: Geburtshilfe und Frauenheilkunde
Published: November 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022) - Part 2 with Recommendations on the Therapy of Precancerous Lesions and Early-stage Endometrial Cancer, Surgical Therapy, Radiotherapy and Drug-based Therapy, Follow-up Care, Recurrence and Metastases, Psycho-oncological Care, Palliative Care, Patient Education, and Rehabilitative and Physiotherapeutic Care.
Journal: Geburtshilfe und Frauenheilkunde
Published: March 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures.
Journal: Geburtshilfe und Frauenheilkunde
Published: March 17, 2023
Adjuvant Docetaxel in Node-Negative Breast Cancer Patients: A Randomized Trial of AGO-Breast Study Group, German Breast Group, and EORTC-Pathobiology Group.
Journal: Cancers
Published: February 01, 2023
Last Updated: 09/26/2026